Bharat Parenterals (BPLPHARMA) Share Price Falls 10.65% as Small Cap Pharma Weakens
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Bharat Parenterals Share Price moved sharply lower in today’s trade, with Bharat Parenterals last traded at Rs 1,909.85, down 10.65% from the previous close, and the company carrying a market capitalisation of Rs 1,306.1 crore. The Bharat Parenterals Share Price move places the stock squarely in today’s decliner list within the healthcare space, but the visible data itself does not establish a company-specific trigger. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Bharat Parenterals Share Price Today, the key point is that the fall came from a starting point above Rs 2,100 and pushed the stock materially lower during the ongoing session.
As a Bharat Parenterals Share Price update, the move is relevant because the stock is a Small Cap, and the gap between the day’s opening level and the latest trade shows a clear intraday reset in the Bharat Parenterals Share Price. The next sections break down price action, valuation, sector context and peers to put the Bharat Parenterals Share Price decline in perspective.
Bharat Parenterals (BPLPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,909.85 |
| Previous Close | Rs 2,137.45 |
| Today's Move | -Rs 227.60 (-10.65%) |
| Open | Rs 2,157.1 |
| High | Rs 2,214 |
| Low | Rs 1,856 |
| Market Capitalisation | Rs 1,306.1 crore |
| Market Cap Category | Small Cap |
Bharat Parenterals Share Price opened at Rs 2,157.1, touched a high of Rs 2,214 and a low of Rs 1,856, before last trading at Rs 1,909.85. The previous close stood at Rs 2,137.45, so the Bharat Parenterals Share Price decline of Rs 227.6 translated into a 10.65% fall. The gap between the day’s high and low was wide, and the current trade is much closer to the day’s low than the day’s high, which makes the Bharat Parenterals Share Price move important for short-term stock watchers.
In company-size terms, Bharat Parenterals is classified as a Small Cap, and its market capitalisation of Rs 1,306.1 crore sits above the sector median of the same industry but far below the sector average, which is pulled up by very large listed pharma names. That combination makes Bharat Parenterals Share Price Today a useful case study in price action for a smaller healthcare name. With no verified trigger disclosed, the Bharat Parenterals Share Price fall remains a confirmed market event rather than a narrative about cause.
Bharat Parenterals (BPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,306.1 crore |
| P/B Ratio | 4.62x |
| ROE | -8.36% |
| ROCE | -1.82% |
| EPS | Rs -22.35 |
| Book Value Per Share | Rs 462.38 |
| Dividend Yield | 0.05% |
The Bharat Parenterals Share Price should be read alongside the company’s valuation and return ratios. Bharat Parenterals trades at a price-to-book ratio of 4.62, while the book value is Rs 462.38 per share. Its EPS is Rs -22.35, ROE is -8.36% and ROCE is -1.82%, which indicates that the current Bharat Parenterals Share Price is not being supported by positive reported earnings or positive capital returns in the latest figures provided. The dividend yield is 0.05%, so income yield is not a major feature of the Bharat Parenterals Share Price story.
From a valuation lens, the Bharat Parenterals Share Price is being assessed against negative earnings and a P/B that is above the same-industry median. That does not by itself explain the fall, but it does show why Bharat Parenterals Share Price Today attracts close scrutiny from stock analysis readers. Market capitalisation of Rs 1,306.1 crore shows that this is not a large pharma heavyweight; it is a Small Cap with a very different risk profile from the sector leaders.
For Bharat Parenterals Share Price News readers, the fundamental analysis is straightforward: the latest reported profitability ratios are negative, the book value is known, and the dividend yield is minimal. Those facts keep Bharat Parenterals Share Price under analytical watch even when no fresh company event is visible. The next step is to compare those numbers with the healthcare sector and the broader pharmaceutical industry benchmark.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 4.62x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 4.34x |
| Company ROE | -8.36% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | -1.82% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 1,306.1 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
| Benchmark Average Market Cap | Rs 14,389.26 crore |
Bharat Parenterals Share Price sits inside the Healthcare sector and the Pharmaceuticals & Drugs industry, where the same-industry benchmark covers 199 companies. Within that group, the benchmark P/E median is 32.59, the average is 49, and the range spans from 3.46 to 707.31. Bharat Parenterals itself has no positive earnings multiple shown in the latest figures because EPS is negative, so the Bharat Parenterals Share Price must be interpreted more through book value and return ratios than through a conventional earnings multiple.
On book value, the sector median P/B is 2.88 and the average is 4.34, while Bharat Parenterals carries a P/B of 4.62. That places the Bharat Parenterals Share Price above the median and slightly above the average on this measure. The benchmark ROE median is 11.7% and the average is 10.68%, while Bharat Parenterals shows ROE of -8.36%. ROCE tells a similar story: the sector median is 13.61% and the average is 13.4%, versus Bharat Parenterals at -1.82%. In other words, Bharat Parenterals Share Price is trading with weaker return ratios than the typical company in the same industry benchmark.
The market capitalisation benchmark also helps frame the Bharat Parenterals Share Price move. The same-industry median market cap is Rs 783.26 crore and the average is Rs 14,389.26 crore. Bharat Parenterals at Rs 1,306.1 crore sits above the median but far below the average, reflecting how concentrated the pharmaceutical sector is around a few very large companies. For Bharat Parenterals Share Price analysis, that means sector comparisons should lean on relative valuation and returns rather than on size alone.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Peer comparison is important for Bharat Parenterals Share Price because the stock’s valuation ratios and return metrics can be checked against other listed pharma names. Among the peers shown, Sun Pharmaceutical Industries has a P/E of 36.5, P/B of 5.1, ROE of 14.85% and ROCE of 19.11%, while Divi’s Laboratories carries a P/E of 86.51, P/B of 14.33, ROE of 16.19% and ROCE of 21.51%.
Against those higher-priced peers, Bharat Parenterals Share Price looks different because its EPS is negative and its ROE and ROCE are negative. Torrent Pharmaceuticals shows even higher valuation at P/E of 84.92 and P/B of 20.64, with ROE of 26.76% and ROCE of 19.27%. Zydus Lifesciences reports P/E of 26.79, P/B of 4.48, ROE of 19.69% and ROCE of 21.39%, while Cipla shows P/E of 33.29, P/B of 3.19, ROE of 11.83% and ROCE of 16%.
In this peer set, Bharat Parenterals Share Price stands out mainly for its negative return ratios rather than for an extreme valuation premium. Its market cap of Rs 1,306.1 crore is also much smaller than the listed peer group shown here, which stretches from over Rs 100,000 crore to more than Rs 444,000 crore. For Bharat Parenterals Share Price Today, that scale difference matters when reading the stock’s fundamentals and sector positioning.
Why Investors Are Watching Bharat Parenterals
- Bharat Parenterals Share Price fell 10.65% in the current session, making it a notable stock move in today’s trade.
- The stock last traded at Rs 1,909.85, well below the previous close of Rs 2,137.45.
- Bharat Parenterals Share Price is linked to a Small Cap pharma company, which often draws close monitoring when price action is sharp.
- Negative EPS, ROE and ROCE keep Bharat Parenterals Share Price under fundamental analysis scrutiny.
- The company’s P/B of 4.62 is above the same-industry median, which adds valuation context to the Bharat Parenterals Share Price story.
About Bharat Parenterals
Bharat Parenterals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s latest visible profile places it within the listed pharmaceutical universe where investors compare product-led businesses, valuation ratios and return metrics. Bharat Parenterals Share Price is therefore read not just as a market quote, but as a reflection of how the company is being priced against its peers, book value and capital efficiency. The business description in the latest figures is to sector and industry identity, so the Bharat Parenterals Share Price narrative remains anchored to those verified details and the financial ratios disclosed here.
Track Bharat Parenterals Share Price on Univest
Use Bharat Parenterals (BPLPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers tracking Bharat Parenterals Share Price can follow live updates, market cap, fundamental ratios, 52-week levels and company insights on Univest. Bharat Parenterals Share Price Today can also be reviewed alongside sector context, peer numbers and valuation metrics in one place. For Bharat Parenterals Share Price News, Univest keeps the company page focused on factual market data and core financial context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Bharat Parenterals Share Price falling today?
Ans. Bharat Parenterals Share Price fell 10.65% to Rs 1,909.85 in today’s trade. Univest data confirms the move itself, though no company-specific trigger has been identified. The move is visible in the day range as well.
What is Bharat Parenterals Share Price today?
Ans. Bharat Parenterals Share Price was last traded at Rs 1,909.85. It opened at Rs 2,157.1, touched a high of Rs 2,214 and a low of Rs 1,856, showing a wide intraday range during the ongoing session.
How much did Bharat Parenterals Share Price change from the previous close?
Ans. Bharat Parenterals Share Price declined by Rs 227.6 from the previous close of Rs 2,137.45. That change equals 10.65%, which makes the stock one of the sharper movers in today’s trade.
What is Bharat Parenterals market capitalisation?
Ans. Bharat Parenterals has a market capitalisation of Rs 1,306.1 crore. The company is classified as a Small Cap, which gives the Bharat Parenterals Share Price move a different context from larger pharma peers.
Is Bharat Parenterals Share Price supported by earnings?
Ans. The latest figures show EPS of Rs -22.35, ROE of -8.36% and ROCE of -1.82%. Those numbers do not provide earnings support to Bharat Parenterals Share Price in the latest reported snapshot.
How does Bharat Parenterals compare with pharma peers?
Ans. Bharat Parenterals Share Price compares with peers that show positive return ratios and, in many cases, much larger market capitalisation. Sun Pharma, Zydus Lifesciences and Cipla all show positive ROE and ROCE in the peer set.
What does the Bharat Parenterals P/B ratio mean?
Ans. Bharat Parenterals has a P/B ratio of 4.62 and book value of Rs 462.38 per share. That means the Bharat Parenterals Share Price is trading above book value, while sector comparison shows the ratio is above the industry median.
Should investors track Bharat Parenterals Share Price on Univest?
Ans. Bharat Parenterals Share Price can be tracked on Univest for live updates, valuation ratios, sector context and market cap data. The page is useful for following Bharat Parenterals Share Price Today and broader stock analysis in one place.
